title: Molecular Variants of HPV Type 16 E6 Among Honduran Women.
abstract: OBJECTIVE
  In this study, we investigated the prevalence of human papillomavirus 16 (HPV-16) variants in Honduran women with normal cytology and with dysplasia and cervical cancer.
  
  
  METHODS
  Samples identified as positive for HPV-16 by SPF10-LiPA were tested for intratypic subtypes and variants by analysis of the E6/E7 region using a novel reverse hybridization assay (line probe assay).
  
  
  RESULTS
  We found that most infections in all clinical groups belong to the E6 European variants, suggesting that HPV-16 non-European variants do not represent an additional factor associated with increased occurrence of high-grade cervical lesions in the studied population. Among the 106 HPV-16-positive women analyzed, E-350G was the most prevalent variant in all different disease stages, being present in 18% of cervical cancer, 13% of cervical intraepithelial neoplasia grade III (CIN III), 5% of CIN II, 5% of CIN I, and 20% of control samples. Mixed variants of HPV-16 infections were detected in 7.7% of the samples, mostly in women with normal cytology.
  
  
  CONCLUSIONS
  This study shows for the first time the diversity of HPV-16 variants in cervical samples of Honduran women.
authors.affiliation: School of Microbiology, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
authors.forename: Nelba
authors.initials: N
authors.lastname: Tabora
authors.forename: Willem J G
authors.initials: WJ
authors.lastname: Melchers
authors.forename: Leen-Jan
authors.initials: LJ
authors.lastname: van Doorn
authors.forename: Wim
authors.initials: W
authors.lastname: Quint
authors.forename: Annabelle
authors.initials: A
authors.lastname: Ferrera
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics*; D016022:Case-Control Studies; D002584:Cervix Uteri / Q000378:metabolism / Q000473:pathology; D004279:DNA, Viral / Q000235:genetics; D018450:Disease Progression; D005260:Female; D014644:Genetic Variation; D006721:Honduras; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D009856:Oncogene Proteins, Viral / Q000235:genetics*; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000821:virology*; D011379:Prognosis; D012097:Repressor Proteins / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000821:virology*; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000821:virology*
chemical_list: D014408:Biomarkers, Tumor; D004279:DNA, Viral; C068651:E6 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D012097:Repressor Proteins